Delivery Order SPE2DB22D1017-SPE2DB24FG3BL

Award Date 8/12/24
Potential Completion Date 8/13/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,158.48 firm fixed-price delivery order is for the supply of ULORIC 80 MG TABLET 30S, a generic pharmaceutical product. The contract has a completion date of June 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ULORIC 40 MG TABLET 30S. The fixed-price contract has a ceiling value of $2,077.25 and runs through November 2023. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and has no set-aside designation, indicating open competition. This delivery order is likely part of a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $2,810.20, is for the delivery of 4563458673 ULORIC 40 MG TABLET 30S, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing arrangement. The award has an ultimate completion date of January 29, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Uloric 80mg tablets. The award has a ceiling value of $2,990.19 and an ultimate completion date of November 20, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,421.22 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 100 units of URSODIOL 500 MG TABLET. This award, with a completion date of July 26, 2024, is placed under an Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical. The IDC enables DLA to efficiently procure a comprehensive range of...
The U.S. Department of Defense's Medical Supply Chain has awarded a $53,367.30 firm fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,558,845,821 units of the prescription medication Uroxatral 10 mg tablets in 100-count packages. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,920.91 Firm Fixed Price Delivery Order contract is for the supply of ORSERDU 345 MG TABLET 30S, a pharmaceutical product, with a period of performance through February 5, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,633.92, is a delivery order contract with a firm fixed price for the supply of febuxostat 40 mg tablets. The contract has an ultimate completion date of April 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a $10,750.82 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides a range of pharmaceutical products and medical supplies to support military healthcare programs globally. It is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for procuring essential...
This is a $1,418.40 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides for the delivery of various medical and pharmaceutical products to support military and government healthcare requirements, including medications across therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG3BL
    Delivery Order

This $1,336.98 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ULORIC 40 MG TABLET 30S, a prescription medication, to support military treatment programs and facilities. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for a broad range of pharmaceutical and medical supplies. The contract does not have a set-aside designation and is expected to be completed by August 13, 2024. AmerisourceBergen's extensive supply chain and distribution capabilities enable it to provide critical pharmaceutical and medical products to the U.S. government, contributing to the healthcare needs of military personnel and other federal beneficiaries.

Generated 11/11/24, 9:08 AM